Genetically-associated chronic obstructive pulmonary disease treatment
AssigneePneumRx, Inc.
InventorsMark L. Mathis, Kara Andersen Reiter
Life of this patent
Estimating the term…
Abstract
A method for treating a genetically associated chronic obstructive pulmonary disease. At least one implant is advanced into an airway of a lung having a genetically associated chronic obstructive pulmonary disease. The at least one implant is delivered into the lung to increase tension of the lung and thereby improve breathing function of the lung.
Claims20
A system for treating a patient presenting with a genetically associated chronic obstructive pulmonary disease, the system comprising:
- a sterile, biocompatible, self-recovering coil implant, wherein the coil implant is delivered into an airway of a lung of the patient in a straight configuration and recovers to a non-straight, pre-determined shape upon deployment within the airway the lung of the patient;
- a sterile, biocompatible, disposable, single-use single-patient delivery system, wherein the delivery system includes a guidewire, a catheter, a cartridge, and forceps;
- and
- a genetic diagnostic test sample delivery system for transmitting a genetic specimen from the patient to a genetic diagnostic system configured for diagnosing an alpha-1 antitrypsin deficiency, and for providing an indication suitable for prompting use of the coil implant.
A system for treating a genetically associated chronic obstructive pulmonary disease, comprising:
- a means for increasing tension of a lung having alveolar damage caused by alpha-1 antitrypsin deficiency and thereby improve breathing function of the lung;
- and
- a means for diagnosing the alpha-1 antitrypsin deficiency, wherein the means for diagnosing provides an indication suitable for prompting use of at least one delivery catheter.
A system for treating a genetically associated chronic obstructive pulmonary disease, comprising:
- at least one implant device configured to increase tension of a lung having alveolar damage caused by alpha-1 antitrypsin deficiency;
- at least one delivery catheter for delivering the at least one implant device to the lung;
- and
- a genetic diagnostic test sample delivery system for transmitting a genetic specimen from the patient to a genetic diagnostic system configured for diagnosing the alpha-1 antitrypsin deficiency, and for providing an indication suitable for prompting use of the at least one delivery catheter.
Dependencies are inferred from the claim text.